Dr. Katie Beleznay showcases the effects of Botox by injecting one side of her husband's face, revealing the differences in a clear before-and-after demonstration. This unique approach demystifies ...
Chronic pelvic pain is a common and complex condition that significantly affects women’s quality of life. Neuropathic pain and nociplastic pain are important components in the pain picture of these ...
Abstract: The human brain is exceedingly good at learning rich narratives from highly limited experiences. One of the ways this is achieved in our brain is through neuromodulators or neurotransmitters ...
This summary of a Cochrane review presents what we know from research about the effect of neuromodulators on pain in patients with rheumatoid arthritis. The review shows that in people with rheumatoid ...
Like Kleenex, ChapStick, and Band-Aid, Botox is such a leader in its field that the brand name itself is regularly used to refer to the generic product it represents. For those who are unaware, "Botox ...
Researchers have shown in mice that brain cells known as astrocytes are required for a signaling chemical called norepinephrine to modify brain activity, changing the textbook understanding that ...
Once thought to play a supporting function in the brain, new research shows non-neuronal astroglial cells perform a leading role in regulating the activity of neurons and their connections. In 2019, ...
Summary: For nearly a century, scientists believed that neuromodulators like norepinephrine adjusted brain communication by acting directly on neurons. A new study overturns this long-held view, ...
Summary: Astrocytes, once thought to be mere support cells, are now shown to play a leading role in regulating behavior by modulating neuronal activity through slow biochemical circuits. In zebrafish, ...
Galderma’s performance was broad-based across all three of its product categories, with particularly strong results in neuromodulators. The following chart illustrates the company’s net sales growth ...
Investing.com -- Galderma (SIX:GALD) shares jumped more than 7% on Thursday after the company posted first-quarter results that exceeded expectations, driven by strong sales of neuromodulators and a ...